000 | 01272 a2200337 4500 | ||
---|---|---|---|
005 | 20250515080250.0 | ||
264 | 0 | _c20071029 | |
008 | 200710s 0 0 eng d | ||
022 | _a1871-5273 | ||
024 | 7 |
_a10.2174/187152707781387279 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVikelis, Michail | |
245 | 0 | 0 |
_aThe role of glutamate and its receptors in migraine. _h[electronic resource] |
260 |
_bCNS & neurological disorders drug targets _cAug 2007 |
||
300 |
_a251-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGlutamic Acid _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
650 | 0 | 4 |
_aReceptors, AMPA _xdrug effects |
650 | 0 | 4 |
_aReceptors, Glutamate _xdrug effects |
650 | 0 | 4 |
_aReceptors, Kainic Acid _xdrug effects |
650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xdrug effects |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xdrug effects |
650 | 0 | 4 |
_aTrigeminal Nerve _xdrug effects |
700 | 1 | _aMitsikostas, Dimos D | |
773 | 0 |
_tCNS & neurological disorders drug targets _gvol. 6 _gno. 4 _gp. 251-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/187152707781387279 _zAvailable from publisher's website |
999 |
_c17223729 _d17223729 |